Pfizer Limited and Pakistan Bait-ul-Mal have signed a Memorandum of Understanding (MoU) to support patient diagnosed with Cancer and are under critical care which are beyond conventional therapies. The signing ceremony was held in Islamabad. This collaboration is part of Pfizer’s patient access program’MASEEHA’, an initiative to broaden access to Pfizer critical care and cancer medicines. Country Manager of Pfizer Pakistan, Syed Wajih, in his message at the MoU inking ceremony said, “We are very pleased to share that we are making significant investments in patient’s access program in collaboration with Pakistan Bait-ul-Maal, Government of Pakistan. The MoU stands out as an excellent example of cooperation between these two organizations in an area of public health for those patients who don’t have access to these crucial medicines to enhance their quality of life. Managing Director Bait-ul-Mal, Aon Abbas Bupi recognized the importance of this partnership for the betterment of the society and especially for those deserving patients who do not have the financial support for purchasing these medicines. He further elaborated that the overall objective was to provide medical assistance to the deserving for better patient management care across Pakistan. Published in Daily Times, January 18th 2019.